Somatic gene targeting with RNA/DNA chimeric oligonucleotides: An analysis with a sensitive reporter mouse system

Journal of Gene Medicine

Volumn 6, Issue 11, 2004, Pages 1272-1280

  Ino, Asami ^a   Yamamoto, Seiji ^b   Kaneda, Yasufumi ^b   Kobayashi, Ichizo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Gene targeting; HVJ liposome; MutaMouse; RNA DNA oligonucleotides

Indexed keywords

BETA GALACTOSIDASE; BETA GALACTOSIDE; DNA; GENE PRODUCT; LIPOSOME; OLIGONUCLEOTIDE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE LAMBDA; CHIMERA; CHROMOSOME; CONTROLLED STUDY; DNA EXTRACTION; DNA PACKAGING; DNA REPAIR; DRUG DETERMINATION; DRUG SENSITIVITY; ENZYME ACTIVE SITE; FREQUENCY ANALYSIS; GENE CONSTRUCT; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC SELECTION; HETEROZYGOTE; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; MEASUREMENT; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; POINT MUTATION; PRIORITY JOURNAL; RELIABILITY; REPORTER GENE; RESTRICTION MAPPING; SEQUENCE ANALYSIS; SOMATIC GENE THERAPY; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BACTERIOPHAGE LAMBDA; BASE SEQUENCE; DNA REPAIR; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENES, REPORTER; LAC OPERON; LIPOSOMES; LIVER; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDES, ANTISENSE; OLIGORIBONUCLEOTIDES, ANTISENSE; POINT MUTATION;

MUS MUSCULUS; RODENTIA;

EID: 13644267926     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.617     Document Type: Article

References (31)

1. Yanez RJ, Porter AC. Therapeutic gene targeting. Gene Ther 1998; 5: 149-159.
2. Capecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288-1292.
3. Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998; 4: 285-290.
4. Kren BT, Parashar B, Bandyopadhyay P, et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A 1999; 96: 10 349-10 354.
5. Rando TA, Disatnik MH, Zhou LZ. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci U S A 2000; 97: 5363-5368.
6. Beetham PR, Kipp PB, Sawycky XL, et al. A tool for functional plant genomics: chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations. Proc Natl Acad Sci U S A 1999; 96 8774-8778.
7. Yoon K, Cole-Strauss A, Kmiec EB. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. Proc Natl Acad Sci U S A 1996; 93: 2071-2076.
8. Gamper HB Jr, Cole-Strauss A, Metz R, et al. A plausible mechanism for gene correction by chimeric oligonucleotides. Biochemistry 2000; 39: 5808-5816.
9. Thorpe PH, Stevenson BJ, Porteous DJ. Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides. J Gene Med 2002; 4: 195-204.
10. van der Steege G, Schuilenga-Hut PH, Buys CH, et al. Persistent failures in gene repair. Nat Biotechnol 2001; 19: 305-306.
11. Taubes G. Gene therapy. The strange case of chimeraplasty. Science 2002; 298: 2116-2120.
12. Diaz-Font A, Cormand B, Chabas A, et al. Unsuccessful chimeraplast strategy for the correction of a mutation causing Gaucher disease. Blood Cells Mol Dis 2003; 31: 183-186.
13. Gossen JA, de Leeuw WJ, Tan CH, et al. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci U S A 1989; 86: 7971-7975.
14. Cosentino L, Heddle JA. A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo. Mutagenesis 1999; 14: 113-119.
15. Myhr BC. Validation studies with Muta Mouse: a transgenic mouse model for detecting mutations in vivo. Environ Mol Mutagen 1991; 18: 308-315.
16. Saeki Y, Wataya-Kaneda M, Tanaka E, et al. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes. Gene Ther 1998; 5: 1031-1037.
17. - phage. Mutagenesis 1994; 9: 183-185.
18. - phage using a galactose-sensitive E. coli host. Biotechniques 1993; 14: 326-330.
19. Blakey DH, Douglas GR, Huang KC, et al. Cytogenetic mapping of lambda gt10 lacZ sequences in the transgenic mouse strain 40.6 (Muta Mouse). Mutagenesis 1995; 10: 145-148.
20. Saeki Y, Matsumoto N, Nakano Y, et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997; 8: 2133-2141.
21. Bandyopadhyay P, Ma X, Linehan-Stieers C, et al. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J Biol Chem 1999; 274: 10 163-10 172.
22. Jacobson RH, Zhang XJ, DuBose RF, et al. Three-dimensional structure of beta-galactosidase from E. coli. Nature 1994; 369: 761-766.
23. Cupples CG, Miller JH. Effects of amino acid substitutions at the active site in Escherichia coli beta-galactosidase. Genetics 1988; 120: 637-644.
24. Cole-Strauss A, Gamper H, Holloman WK, et al. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res 1999; 27: 1323-1330.
25. Chen Z, Felsheim R, Wong P, et al. Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair. Biochem Biophys Res Commun 2001; 285: 188-194.
26. Nickerson HD, Colledge WH. A comparison of gene repair strategies in cell culture using a lacZ reporter system. Gene Ther 2003; 10: 1584-1591.
27. Igoucheva O, Alexeev V, Pryce M, et al. Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration. Nucleic Acids Res 2003; 31: 2659-2670.
28. Pierce EA, Liu Q, Igoucheva O, et al. Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Ther 2003; 10: 24-33.
29. Krebs O, Favor J. Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea. Mutat Res 1997; 388: 239-248.
30. Kawamura I, Morishita R, Tsujimoto S, et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 2001; 8: 905-912.
31. Manzano A, Mohri Z, Sperber G, et al. Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts). J Gene Med 2003; 5: 795-802.